| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA207678
Max Phase: Preclinical
Molecular Formula: C19H20N2OS
Molecular Weight: 324.45
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CSc1ccc(CC2(O)c3ccccc3C3=NCCCN32)cc1
Standard InChI: InChI=1S/C19H20N2OS/c1-23-15-9-7-14(8-10-15)13-19(22)17-6-3-2-5-16(17)18-20-11-4-12-21(18)19/h2-3,5-10,22H,4,11-13H2,1H3
Standard InChI Key: DDXKOYBGLFFHEW-UHFFFAOYSA-N
Associated Targets(Human)
NFKB2 Tchem Nuclear factor NF-kappa-B complex (2307 Activities)
Associated Targets(non-human)
Adra1d Alpha-1d adrenergic receptor (1475 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Adra1a Alpha-1a adrenergic receptor (3346 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Adra1b Alpha-1b adrenergic receptor (2470 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Human immunodeficiency virus (3636 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
tat Human immunodeficiency virus type 1 Tat protein (75 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mus musculus (284745 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 324.45 | Molecular Weight (Monoisotopic): 324.1296 | AlogP: 3.26 | #Rotatable Bonds: 3 |
| Polar Surface Area: 35.83 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 12.20 | CX Basic pKa: 5.23 | CX LogP: 3.58 | CX LogD: 3.58 |
| Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.88 | Np Likeness Score: -0.12 |
References
| 1. del Olmo E, Barboza B, Ybarra MI, López-Pérez JL, Carrón R, Sevilla MA, Boselli C, San Feliciano A.. (2006) Vasorelaxant activity of phthalazinones and related compounds., 16 (10): [PMID:16513345] [10.1016/j.bmcl.2006.02.003] |
| 2. Bedoya LM, del Olmo E, Sancho R, Barboza B, Beltrán M, García-Cadenas AE, Sánchez-Palomino S, López-Pérez JL, Muñoz E, San Feliciano A, Alcamí J.. (2006) Anti-HIV activity of stilbene-related heterocyclic compounds., 16 (15): [PMID:16713260] [10.1016/j.bmcl.2006.04.087] |
| 3. Zamilpa A, Herrera-Ruiz M, Del Olmo E, López-Pérez JL, Tortoriello J, San Feliciano A.. (2007) [1,3]Diazaheterofused isoindolol derivatives displaying anxiolytic-like effects on mice., 17 (14): [PMID:17507222] [10.1016/j.bmcl.2007.04.080] |
Source
Source(1):